HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Rhia Ventures Invests in OCON Healthcare’s Ballerine – the 1st & Only 3D Sperical Copper IUB
Rhia Ventures notes the financing will also help expand Phase II clinical trials for OCON's SEADTM product, which offers point-of-care therapy for abnormal uterine bleeding.
Verily Announces $700 Million Investment Round from Current Investors: Funds to Support Rapid Commercial Expansion
Verily current investors, include Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others.
Pacific6 Enterprises and JM Molina Investments Announce a Joint Investment in Detact Diagnostics
Pacific6 is an investment partnership founded, in part, by John Molina, the former CFO of Molina Healthcare. His brother, J. Mario Molina, M.D., former CEO of Molina Healthcare, is the principal behind JM Molina Investments.
Senecio Robotics Awarded $12 Million
With nearly 700 million people infected with a mosquito-borne disease every year, as well as the increase in mosquito populations driven by a warming climate, it is a massive and growing challenge to fight them using only traditional approaches.
osteolabs GmbH Successfully Closes Second Financing Round of Nearly 1.6 Million EUR
The funds raised will be used to promote the further geographical expansion of osteolabs GmbH in the Scandinavian countries, the BENELUX countries, Switzerland and Austria.
Basking Biosciences Completes $5.4M Seed Financing: Funds to Support Development of the 1st Reversible Thrombolytic Therapy for Acute Ischemic Stroke
The investor syndicate includes Rev1 Ventures, Broadview Ventures, and Viva BioInnovator. Concurrent with the financing, Ryan Helon of Rev1, Thomas Needham of Broadview, and Dr. Dan Meyers have joined Basking’s Board of Directors.
Fusion Antibodies and Queen’s University Belfast Awarded a £453,000 Grant from Invest Northern Ireland
The two organisations will use the funds to accelerate the discovery of novel therapeutic and diagnostic antibodies with validated anti-infective properties against COVID-19. Building on strong scientific knowhow, a new antibody development platform will be created that will help realise the vision of producing a breakthrough therapeutic that directly targets SARS-CoV-2.
Kayentis, a global provider of digital data capture systems for clinical trials, today announces it has raised €7M (approx. $8.3M) in growth capital.
Kayentis is active in the global electronic Clinical Outcome Assessment (eCOA) market, which is expected to reach $2.6 billion by 2027. Market growth in eCOA – a method of capturing outcomes data electronically in clinical trials – is driven by the clinical trials industry.
MapLight Therapeutics Receives $8.1 Million For Parkinson’s Disease Research
To undertake a large-scale, systematic investigation of the brain circuits and mechanisms that are responsible for triggering psychiatric symptoms in Parkinson's disease.
